Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Gut microbiome activity predicts risk of type 2 diabetes and metformin control in a large human cohort

Nan Shen, Nevenka Dimitrova, Cleo H. Ho, Pedro J. Torres, Francine R Camacho, Ying Cai, Momchilo Vuyisich, Damon Tanton, Guruduth Banavar
doi: https://doi.org/10.1101/2021.08.13.21262051
Nan Shen
1Viome Research Institute, Viome Inc, Seattle, WA and New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nevenka Dimitrova
2New York Medical College, Valhalla, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cleo H. Ho
1Viome Research Institute, Viome Inc, Seattle, WA and New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro J. Torres
1Viome Research Institute, Viome Inc, Seattle, WA and New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francine R Camacho
1Viome Research Institute, Viome Inc, Seattle, WA and New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ying Cai
1Viome Research Institute, Viome Inc, Seattle, WA and New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Momchilo Vuyisich
1Viome Research Institute, Viome Inc, Seattle, WA and New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Damon Tanton
3Endocrinology, Diabetes And Metabolism, AdventHealth, Orlando, FL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guruduth Banavar
1Viome Research Institute, Viome Inc, Seattle, WA and New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: guru@viome.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Data Availability

Summary data is available within the Article and Supplementary Information. Research requiring additional data can visit https://www.viome.com/vri/data-access, through which we provide access to summary statistics through a Data Transfer Agreement that protects the privacy of our participants' data.

Back to top
PreviousNext
Posted August 18, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Gut microbiome activity predicts risk of type 2 diabetes and metformin control in a large human cohort
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Gut microbiome activity predicts risk of type 2 diabetes and metformin control in a large human cohort
Nan Shen, Nevenka Dimitrova, Cleo H. Ho, Pedro J. Torres, Francine R Camacho, Ying Cai, Momchilo Vuyisich, Damon Tanton, Guruduth Banavar
medRxiv 2021.08.13.21262051; doi: https://doi.org/10.1101/2021.08.13.21262051
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Gut microbiome activity predicts risk of type 2 diabetes and metformin control in a large human cohort
Nan Shen, Nevenka Dimitrova, Cleo H. Ho, Pedro J. Torres, Francine R Camacho, Ying Cai, Momchilo Vuyisich, Damon Tanton, Guruduth Banavar
medRxiv 2021.08.13.21262051; doi: https://doi.org/10.1101/2021.08.13.21262051

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Endocrinology (including Diabetes Mellitus and Metabolic Disease)
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (500)
  • Anesthesia (110)
  • Cardiovascular Medicine (1230)
  • Dentistry and Oral Medicine (205)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (529)
  • Epidemiology (10005)
  • Forensic Medicine (5)
  • Gastroenterology (497)
  • Genetic and Genomic Medicine (2445)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1635)
  • Health Policy (751)
  • Health Systems and Quality Improvement (633)
  • Hematology (248)
  • HIV/AIDS (531)
  • Infectious Diseases (except HIV/AIDS) (11855)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (251)
  • Medical Ethics (74)
  • Nephrology (267)
  • Neurology (2273)
  • Nursing (139)
  • Nutrition (350)
  • Obstetrics and Gynecology (452)
  • Occupational and Environmental Health (532)
  • Oncology (1244)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (154)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (729)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4824)
  • Radiology and Imaging (833)
  • Rehabilitation Medicine and Physical Therapy (488)
  • Respiratory Medicine (650)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (225)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (124)
  • Urology (99)